Our Vision for the Future
To Save Lives with Early Detection of Lung Cancer
At VisionGate, our mission is to save lives through the early detection and prevention of cancer. Our cutting-edge technologies are designed to accurately and quickly detect early-stage lung cancer using a simple, non-intrusive test.
We’re backed by a talented team of scientists, researchers, and doctors.
With over 150 years of combined experience, our team at VisionGate has considerable knowledge in the creation of cutting-edge technologies in fields including pharmaceuticals and diagnostics.
Consisting of scientists, researchers, and doctors with backgrounds in a broad range of fields, we’ve put our heads together to develop world class early stage lung cancer detection methods.
Sputum (phlegm) samples from a deep cough (LuCED° Lung Test) are collected over a three-day period using a take-home test kit.
AI-Powered Cancer Detection
Our AI-based classification of cells can identify 1,000 cell images per second and over 800 3D cell features at a 200 nanometer isotropic resolution.